These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 14202259)

  • 1. IMMUNIZATION AGAINST RIFT VALLEY FEVER VIRUS. STUDIES ON THE IMMUNOGENICITY OF LYOPHILIZED FORMALIN-INACTIVATED VACCINE.
    RANDALL R; BINN LN; HARRISON VR
    J Immunol; 1964 Aug; 93():293-9. PubMed ID: 14202259
    [No Abstract]   [Full Text] [Related]  

  • 2. PROTECTION OF MICE AND LAMBS AGAINST PANTROPIC RIFT VALLEY FEVER VIRUS, USING IMMUNE SERUM.
    BENNETT DG; GLOCK RD; GERONE PJ
    Am J Vet Res; 1965 Jan; 26():57-61. PubMed ID: 14269221
    [No Abstract]   [Full Text] [Related]  

  • 3. Stability of a formalin-inactivated Rift Valley fever vaccine: evaluation of a vaccination campaign for cattle in Mozambique.
    Lagerqvist N; Moiane B; Bucht G; Fafetine J; Paweska JT; Lundkvist A; Falk KI
    Vaccine; 2012 Oct; 30(46):6534-40. PubMed ID: 22947138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates.
    Terasaki K; Tercero BR; Makino S
    Virus Res; 2016 May; 216():55-65. PubMed ID: 26022573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An inactivated rift valley fever vaccine.
    Barnard BJ; Botha MJ
    J S Afr Vet Assoc; 1977 Mar; 48(1):45-8. PubMed ID: 874947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study.
    Rusnak JM; Gibbs P; Boudreau E; Clizbe DP; Pittman P
    Vaccine; 2011 Apr; 29(17):3222-9. PubMed ID: 21354483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on DNA immune of envelope protein gene of Rift Valley Fever Virus].
    Wang QH; Wang XJ; Hu S; Ge JY; Bu ZG
    Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):677-81. PubMed ID: 17944371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a formalin-inactivated Rift Valley fever vaccine in sheep.
    Harrington DG; Lupton HW; Crabbs CL; Peters CJ; Reynolds JA; Slone TW
    Am J Vet Res; 1980 Oct; 41(10):1559-64. PubMed ID: 7224281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of laboratory staff to vaccination with an inactivated Rift Valley fever vaccine--TSI-GSD 200.
    Frank-Peterside N
    Afr J Med Med Sci; 2000 Jun; 29(2):89-92. PubMed ID: 11379456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization against Rift Valley fever. The development of vaccines from nonprimate cell cultures and chick embryos.
    BINN LN; RANDALL R; HARRISON VR; GIBBS CJ; AULISIO CG
    Am J Hyg; 1963 Mar; 77():160-8. PubMed ID: 13968362
    [No Abstract]   [Full Text] [Related]  

  • 11. Vaccination of alpacas against Rift Valley fever virus: Safety, immunogenicity and pathogenicity of MP-12 vaccine.
    Rissmann M; Ulrich R; Schröder C; Hammerschmidt B; Hanke D; Mroz C; Groschup MH; Eiden M
    Vaccine; 2017 Jan; 35(4):655-662. PubMed ID: 28012779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of a formalin-killed Rift Valley fever virus vaccine for use in man.
    RANDALL R; GIBBS CJ; AULISIO CG; BINN LN; HARRISON VR
    J Immunol; 1962 Nov; 89():660-71. PubMed ID: 13990748
    [No Abstract]   [Full Text] [Related]  

  • 13. A SLOWLY SEDIMENTING INFECTIOUS COMPONENT OF RIFT VALLEY FEVER VIRUS.
    POLSON A; LEVITT J
    J Hyg (Lond); 1963 Dec; 61(4):451-69. PubMed ID: 14099024
    [No Abstract]   [Full Text] [Related]  

  • 14. Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate.
    Ikegami T
    Expert Rev Vaccines; 2017 Jun; 16(6):601-611. PubMed ID: 28425834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of veterinary vaccines for prevention and control of Rift Valley fever: memorandum from a WHO/FAO meeting.
    Bull World Health Organ; 1983; 61(2):261-8. PubMed ID: 6602663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rift Valley fever vaccine--antibody and immune response in cattle to a live and an inactivated vaccine.
    Barnard BJ
    J S Afr Vet Assoc; 1979 Sep; 50(3):155-7. PubMed ID: 551199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of three candidate Rift Valley fever vaccines in sheep.
    Kortekaas J; Antonis AF; Kant J; Vloet RP; Vogel A; Oreshkova N; de Boer SM; Bosch BJ; Moormann RJ
    Vaccine; 2012 May; 30(23):3423-9. PubMed ID: 22449427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rift Valley fever virus: A review of diagnosis and vaccination, and implications for emergence in Europe.
    Mansfield KL; Banyard AC; McElhinney L; Johnson N; Horton DL; Hernández-Triana LM; Fooks AR
    Vaccine; 2015 Oct; 33(42):5520-5531. PubMed ID: 26296499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A DNA vaccine encoding ubiquitinated Rift Valley fever virus nucleoprotein provides consistent immunity and protects IFNAR(-/-) mice upon lethal virus challenge.
    Boshra H; Lorenzo G; Rodriguez F; Brun A
    Vaccine; 2011 Jun; 29(27):4469-75. PubMed ID: 21549790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One Health approach to Rift Valley fever vaccine development.
    Kortekaas J
    Antiviral Res; 2014 Jun; 106():24-32. PubMed ID: 24681125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.